133 related articles for article (PubMed ID: 25052763)
1. Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes.
Fan X; Hashem AM; Chen Z; Li C; Doyle T; Zhang Y; Yi Y; Farnsworth A; Xu K; Li Z; He R; Li X; Wang J
Mucosal Immunol; 2015 Jan; 8(1):211-20. PubMed ID: 25052763
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism.
Watanabe A; McCarthy KR; Kuraoka M; Schmidt AG; Adachi Y; Onodera T; Tonouchi K; Caradonna TM; Bajic G; Song S; McGee CE; Sempowski GD; Feng F; Urick P; Kepler TB; Takahashi Y; Harrison SC; Kelsoe G
Cell; 2019 May; 177(5):1124-1135.e16. PubMed ID: 31100267
[TBL] [Abstract][Full Text] [Related]
3. Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin.
Finney J; Moseman AP; Kong S; Watanabe A; Song S; Walsh RM; Kuraoka M; Kotaki R; Moseman EA; McCarthy KR; Liao D; Liang X; Nie X; Lavidor O; Abbott R; Harrison SC; Kelsoe G
Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2316964120. PubMed ID: 38147556
[TBL] [Abstract][Full Text] [Related]
4. Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice.
He W; Chen CJ; Mullarkey CE; Hamilton JR; Wong CK; Leon PE; Uccellini MB; Chromikova V; Henry C; Hoffman KW; Lim JK; Wilson PC; Miller MS; Krammer F; Palese P; Tan GS
Nat Commun; 2017 Oct; 8(1):846. PubMed ID: 29018261
[TBL] [Abstract][Full Text] [Related]
5. Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation.
Yang SW; Jang YH; Kwon SB; Lee YJ; Chae W; Byun YH; Kim P; Park C; Lee YJ; Kim CK; Kim YS; Choi SI; Seong BL
FASEB J; 2018 May; 32(5):2658-2675. PubMed ID: 29295864
[TBL] [Abstract][Full Text] [Related]
6. Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus.
Sangesland M; Ronsard L; Kazer SW; Bals J; Boyoglu-Barnum S; Yousif AS; Barnes R; Feldman J; Quirindongo-Crespo M; McTamney PM; Rohrer D; Lonberg N; Chackerian B; Graham BS; Kanekiyo M; Shalek AK; Lingwood D
Immunity; 2019 Oct; 51(4):735-749.e8. PubMed ID: 31563464
[TBL] [Abstract][Full Text] [Related]
7. A Fusion Protein Based on the Second Subunit of Hemagglutinin of Influenza A/H2N2 Viruses Provides Cross Immunity.
Stepanova LA; Sergeeva MV; Shuklina MA; Shaldzhyan AA; Potapchuk MV; Korotkov AV; Tsybalova LM
Acta Naturae; 2016; 8(2):116-26. PubMed ID: 27437146
[TBL] [Abstract][Full Text] [Related]
8. Stability of HA2 Prefusion Structure and pH-Induced Conformational Changes in the HA2 Domain of H3N2 Hemagglutinin.
Eller MW; Siaw HMH; Dyer RB
Biochemistry; 2021 Sep; 60(35):2623-2636. PubMed ID: 34435771
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection.
Zykova AA; Blokhina EA; Stepanova LA; Shuklina MA; Ozhereleva OO; Tsybalova LM; Kuprianov VV; Ravin NV
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764217
[TBL] [Abstract][Full Text] [Related]
10. Mucosal Administration of
Huynh DT; Chathuranga WAG; Chathuranga K; Lee JS; Kim CJ
J Microbiol Biotechnol; 2024 Mar; 34(3):735-745. PubMed ID: 37915251
[TBL] [Abstract][Full Text] [Related]
11. Targeting B cell responses in universal influenza vaccine design.
Kaur K; Sullivan M; Wilson PC
Trends Immunol; 2011 Nov; 32(11):524-31. PubMed ID: 21940217
[TBL] [Abstract][Full Text] [Related]
12. Fusion Protein Consisting of Hemagglutinin Small Subunit and Truncated Nucleoprotein as a Universal Influenza Vaccine Candidate: Starting In-Silico Evaluation Toward
Morshedi F; Nazeri E; Saleh M; Farahmand B
J Pharm Bioallied Sci; 2023; 15(1):57-62. PubMed ID: 37313538
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic and Protective Properties of Recombinant Hemagglutinin of Influenza A (H5N8) Virus.
Rudometova NB; Fando AA; Kisakova LA; Kisakov DN; Borgoyakova MB; Litvinova VR; Yakovlev VA; Tigeeva EV; Vahitov DI; Sharabrin SV; Shcherbakov DN; Evseenko VI; Ivanova KI; Gudymo AS; Ilyicheva TN; Marchenko VY; Ilyichev AA; Rudometov AP; Karpenko LI
Vaccines (Basel); 2024 Jan; 12(2):. PubMed ID: 38400127
[TBL] [Abstract][Full Text] [Related]
14. Advancing universal influenza vaccines: insights from cellular immunity targeting the conserved hemagglutinin stalk domain in humans.
Dong C; Wang BZ
EBioMedicine; 2024 Jun; 104():105172. PubMed ID: 38788629
[No Abstract] [Full Text] [Related]
15. Mechanisms of Influenza Virus HA2 Peptide Interaction with Liposomes Studied by Dual-Wavelength MP-SPR.
Belkilani M; Farre C; Chevalier Y; Minot S; Bessueille F; Abdelghani A; Jaffrezic-Renault N; Chaix C
ACS Appl Mater Interfaces; 2022 Jul; ():. PubMed ID: 35834580
[TBL] [Abstract][Full Text] [Related]
16. Massively parallel de novo protein design for targeted therapeutics.
Chevalier A; Silva DA; Rocklin GJ; Hicks DR; Vergara R; Murapa P; Bernard SM; Zhang L; Lam KH; Yao G; Bahl CD; Miyashita SI; Goreshnik I; Fuller JT; Koday MT; Jenkins CM; Colvin T; Carter L; Bohn A; Bryan CM; Fernández-Velasco DA; Stewart L; Dong M; Huang X; Jin R; Wilson IA; Fuller DH; Baker D
Nature; 2017 Oct; 550(7674):74-79. PubMed ID: 28953867
[TBL] [Abstract][Full Text] [Related]
17. Prospects of HA-based universal influenza vaccine.
Hashem AM
Biomed Res Int; 2015; 2015():414637. PubMed ID: 25785268
[TBL] [Abstract][Full Text] [Related]
18. Infection of influenza virus neuraminidase-vaccinated mice with homologous influenza virus leads to strong protection against heterologous influenza viruses.
He B; Chang H; Liu Z; Huang C; Liu X; Zheng D; Fang F; Sun B; Chen Z
J Gen Virol; 2014 Dec; 95(Pt 12):2627-2637. PubMed ID: 25170051
[TBL] [Abstract][Full Text] [Related]
19. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.
Ellebedy AH; Krammer F; Li GM; Miller MS; Chiu C; Wrammert J; Chang CY; Davis CW; McCausland M; Elbein R; Edupuganti S; Spearman P; Andrews SF; Wilson PC; García-Sastre A; Mulligan MJ; Mehta AK; Palese P; Ahmed R
Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13133-8. PubMed ID: 25157133
[TBL] [Abstract][Full Text] [Related]
20. Progress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine.
Prabakaran M; Leyrer S; He F; Auer S; Kumar SR; Kindsmueller K; Mytle N; Schneider J; Lockhart S; Kwang J
PLoS One; 2014; 9(9):e107316. PubMed ID: 25229722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
